tradingkey.logo

Clearpoint Neuro Inc

CLPT
15.810USD
-2.420-13.27%
Cierre 11/07, 16:00ETCotizaciones retrasadas 15 min
449.45MCap. mercado
PérdidaP/E TTM

Clearpoint Neuro Inc

15.810
-2.420-13.27%

Más Datos de Clearpoint Neuro Inc Compañía

ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company’s flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.

Información de Clearpoint Neuro Inc

Símbolo de cotizaciónCLPT
Nombre de la empresaClearpoint Neuro Inc
Fecha de salida a bolsaJul 03, 2019
Director ejecutivoMr. Joseph Michael Burnett
Número de empleados115
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 03
Dirección120 S. Sierra Avenue
CiudadSOLANA BEACH
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal92075
Teléfono19499006833
Sitio Webhttps://www.clearpointneuro.com/
Símbolo de cotizaciónCLPT
Fecha de salida a bolsaJul 03, 2019
Director ejecutivoMr. Joseph Michael Burnett

Ejecutivos de Clearpoint Neuro Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.08K
-4.84%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
78.87K
+0.71%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+71.68%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
44.08K
-14.51%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-19.96%
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
Ms. B. Kristine (Kris) Johnson
Ms. B. Kristine (Kris) Johnson
Independent Director
Independent Director
--
--
Dr. Linda M. Liau
Dr. Linda M. Liau
Independent Director
Independent Director
--
--
Mr. Jeremy L. Stigall
Mr. Jeremy L. Stigall
Chief Business Officer
Chief Business Officer
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.08K
-4.84%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
78.87K
+0.71%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+71.68%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
44.08K
-14.51%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-19.96%
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Products: Functional neurosurgery
3.43M
37.24%
Services: Biologics and drug delivery
2.87M
31.12%
Products: Biologics and drug delivery
1.87M
20.30%
Product Systems and software products
694.00K
7.53%
Services: Capital equipment and other
350.00K
3.80%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
9.21M
100.00%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Products: Functional neurosurgery
3.43M
37.24%
Services: Biologics and drug delivery
2.87M
31.12%
Products: Biologics and drug delivery
1.87M
20.30%
Product Systems and software products
694.00K
7.53%
Services: Capital equipment and other
350.00K
3.80%

Estadísticas de accionistas

Actualizado: mié., 22 de oct
Actualizado: mié., 22 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
5.28%
The Vanguard Group, Inc.
5.27%
Bigger Capital Funds, LP
4.10%
PTC Therapeutics Inc
3.15%
Geode Capital Management, L.L.C.
2.20%
Otro
80.01%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
5.28%
The Vanguard Group, Inc.
5.27%
Bigger Capital Funds, LP
4.10%
PTC Therapeutics Inc
3.15%
Geode Capital Management, L.L.C.
2.20%
Otro
80.01%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
19.70%
Investment Advisor/Hedge Fund
8.74%
Hedge Fund
7.68%
Individual Investor
5.21%
Corporation
3.15%
Research Firm
2.54%
Venture Capital
0.10%
Bank and Trust
0.09%
Pension Fund
0.08%
Otro
52.71%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
230
11.01M
38.73%
+8.63K
2025Q2
225
12.82M
45.36%
+349.96K
2025Q1
230
12.08M
42.76%
-158.33K
2024Q4
216
11.35M
41.09%
+117.64K
2024Q3
204
10.32M
38.18%
-558.62K
2024Q2
199
10.56M
39.44%
-945.58K
2024Q1
197
10.90M
40.86%
+64.32K
2023Q4
197
9.84M
39.93%
-1.22M
2023Q3
198
9.05M
36.76%
-2.10M
2023Q2
200
8.72M
35.43%
-782.48K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
1.50M
5.27%
+1.13M
+307.45%
Jun 30, 2025
The Vanguard Group, Inc.
1.48M
5.19%
+191.14K
+14.89%
Jun 30, 2025
Bigger Capital Funds, LP
1.17M
4.1%
+31.67K
+2.79%
Jun 30, 2025
PTC Therapeutics Inc
894.58K
3.15%
--
--
Aug 23, 2024
Geode Capital Management, L.L.C.
624.80K
2.2%
+323.43K
+107.32%
Jun 30, 2025
District 2 Capital LP
430.17K
1.51%
+7.77K
+1.84%
Jun 30, 2025
Bigger (Michael)
378.69K
1.33%
--
--
Jun 30, 2025
State Street Investment Management (US)
333.38K
1.17%
+207.53K
+164.91%
Jun 30, 2025
Brown Advisory
330.90K
1.16%
-191.00
-0.06%
Jun 30, 2025
Lane Generational, LLC
258.43K
0.91%
+16.38K
+6.77%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
Fidelity Digital Health ETF
1.58%
Invesco NASDAQ Future Gen 200 ETF
1.01%
iShares Neuroscience and Healthcare ETF
0.95%
iShares Micro-Cap ETF
0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.09%
iShares Russell 2000 Growth ETF
0.04%
Motley Fool Next Index ETF
0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
0.03%
iShares Russell 2000 ETF
0.02%
Proshares Ultra Russell 2000
0.02%
Ver más
Fidelity Digital Health ETF
Proporción1.58%
Invesco NASDAQ Future Gen 200 ETF
Proporción1.01%
iShares Neuroscience and Healthcare ETF
Proporción0.95%
iShares Micro-Cap ETF
Proporción0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.09%
iShares Russell 2000 Growth ETF
Proporción0.04%
Motley Fool Next Index ETF
Proporción0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.03%
iShares Russell 2000 ETF
Proporción0.02%
Proshares Ultra Russell 2000
Proporción0.02%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI